Bronchitol
Product Images NDC 84639-212

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Bronchitol (NDC 84639-212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Arna Pharma Pty Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister And Inhaler Image (Blister And Inhaler Image)

An instructional diagram illustrating components of BRONCHITOL delivery system. It shows a blister pack containing ten capsules on the left and a labeled inhaler on the right with parts identified as cap, mouthpiece, piercing buttons, and single capsule chamber.*

FDA Label Image

Bronchitol 4 Week Carton Image (Bronchitol 4week Carton Image)

BRONCHITOL inhalation powder carton for 40 mg capsules by Arna Pharma Pty Ltd. The label highlights mannitol as the active ingredient, specifies oral inhalation use only, and the package contains 56 blister cards with 560 capsules and 4 Bronchitol devices. Storage and usage instructions, barcode, and manufacturer details are printed on the carton.*

FDA Label Image

Bronchitol 7 Day Carton Image (Bronchitol 7 Day Carton Image)

The packaging label is for BRONCHITOL inhalation powder capsules, containing 40 mg of mannitol per capsule for oral inhalation. The label includes storage instructions, manufacturer and labeler information (Arna Pharma Pty Ltd and Pharmaxis Europe Limited), a barcode, and safety warnings including to not swallow capsules. The package contains 14 blister packs totaling 140 capsules and is marked Rx only.*

FDA Label Image

Bronchitol Tolerance Test Carton Image (Bronchitol Tolerance Test Carton Image)

Packaging label for Bronchitol (mannitol) inhalation powder Tolerance Test, 40 mg per capsule, by Arna Pharma Pty Ltd. The label indicates it is for oral inhalation only, for single patient use, and includes contents such as 10 capsules in a blister pack and a Bronchitol inhaler. It features warnings about completing the tolerance test and storage instructions with a purple and white color scheme.*

FDA Label Image

Pil Figure A Image (Pil Figure A Image)

An instructional illustration showing a basic outline of an inhaler device labeled 'Figure A' alongside a clock icon with the instruction to wait 5 to 15 minutes before the next step.*

FDA Label Image

Pil Figure B Image (Pil Figure B Image)

An instructional illustration labeled 'Figure B' depicting a pair of hands with two droplets above them, likely symbolizing the application or use of drops on the hands.*

FDA Label Image

Pil Figure C Image (Pil Figure C Image)

Illustration showing two hands demonstrating the removal of a cap from an inhaler device. The right hand lifts the cap upwards off the inhaler held by the left hand, indicated by an upward arrow. The figure is labeled as Figure C.*

FDA Label Image

Pil Figure D Image (Pil Figure D Image)

An instructional line drawing showing a hand inserting a capsule into a device, with an arrow indicating the direction to rotate or close the device, labeled as Figure D. This illustration likely demonstrates part of the usage process for the BRONCHITOL inhalation device.*

FDA Label Image

Pil Figure E Image (Pil Figure E Image)

An instructional illustration labeled 'Figure E' depicting a hand holding a device or container with a cap that is being removed by lifting it upwards and away, as indicated by an arrow. The diagram visually guides the user on how to open the cap correctly.*

FDA Label Image

Pil Figure F Image (Pil Figure F Image)

An instructional illustration showing a hand rotating the top part of an inhalation device or inhaler mechanism in a counterclockwise direction, possibly to open or prepare the device for use. It is labeled as Figure F.*

FDA Label Image

Pil Figure G Image (Pil Figure G Image)

An illustration diagram showing how to operate a component by pushing and then releasing it. The figure demonstrates a hand pressing on two sides of a device, followed by releasing it, indicated by directional arrows beneath the images and labeled 'Push Then Release'.*

FDA Label Image

Pil Figure H Image (Pil Figure H Image)

An instructional illustration showing a person exhaling air into a handheld device, likely representing the use of an inhalation or administration device for the medication BRONCHITOL by Arna Pharma Pty Ltd.*

FDA Label Image

Pil Figure I Image (Pil Figure I Image)

An instructional illustration showing four steps of using an inhaler: inhale from the device, then remove it from the mouth, followed by holding breath for 5 seconds. The steps are labeled with corresponding actions and a visual countdown timer for holding breath.*

FDA Label Image

Pil Figure J Image (Pil Figure J Image)

An instructional illustration showing a hand holding a cap above an inhaler device beside an eye, indicating a user should visually confirm the position or condition of the inhaler or cap. The image is labeled Figure J.*

FDA Label Image

Pil Figure K Image (Pil Figure K Image)

An instructional diagram showing a circular arrow next to a blister pack containing ten pills arranged in two columns. The figure is labeled as 'Figure K' and likely relates to usage or handling instructions for BRONCHITOL by Arna Pharma Pty Ltd.*

FDA Label Image

Pil Figure L Image (Pil Figure L Image)

An instructional diagram labeled as Figure L depicting two hands holding a device with an arrow pointing downward, indicating a pressing or pushing action on the top part of the device.*

FDA Label Image

Pil Figure M Image (Pil Figure M Image)

An instructional diagram illustrating a 7-day dosing schedule. It shows 10 capsules are taken in the morning (depicted by a sun icon) and 10 capsules are taken 2 to 3 hours before bedtime (depicted by a moon icon) each day from day 1 through day 7.*

FDA Label Image

Hcp Tolerance Test Instructions (Bronchitol Inhalation Powder 2)

Healthcare practitioner instructions for use of BRONCHITOL (mannitol inhalation powder) 40 mg per capsule for oral inhalation. This detailed guide explains the Bronchitol Tolerance Test (BTT), including steps for pre-assessment calculations, inhalation of capsule contents, criteria for stopping the test, and required equipment. It includes diagrams for inhaler use steps and the test carton contents.*

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure of BRONCHITOL's active ingredient, showing a molecular diagram with multiple hydroxyl (OH) groups attached to a carbon chain with specified stereochemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.